Blog
Cannae Holdings, Inc. Announces Executive Management Succession, Board Refreshment, and Additional Strategic Actions to Unlock Shareholder Value
Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today announced that the Company’s Board of Directors (the “Board”) has approved a series of strategic actions designed to unlock
Pershing Square Holdings, Ltd. Notes New Time for First Quarter 2025 Investor Call
Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today announced that Pershing Square Capital Management, L.P. will now hold its first quarter investor conference call on 22 May 2025 at 18:30 BST
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and
McGrath to Participate in the Bank of America Securities 32nd Annual Industrials, Transportation, and Airlines Key Leaders Conference
McGrath RentCorp (“McGrath” or the “Company”) (Nasdaq: MGRC), a leading business-to-business rental company in North America, today announced that it will participate in investor meetings at the
AbCellera’s Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit
AbCellera (Nasdaq: ABCL) today announced that the United States Court of Appeals for the Federal Circuit (CAFC) has by a Rule 36 Order affirmed judgment of validity of its U.S. Patent No
Outperform with PROS 2025 Set to Showcase AI-Powered Innovation and Industry Leadership in Las Vegas
PROS Holdings, Inc. (NYSE: PRO), a leading provider of AI-powered SaaS pricing and selling solutions, kicked off its flagship event, Outperform with PROS 2025, today at The Cosmopolitan of Las
Median Technologies to Present Scientific Posters on eyonis® LCS in Two Major Health Conferences in North America in May 2025
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software
SAP Cloud Migrations Drive Demand for Ecosystem Services
Enterprises around the world are cautiously migrating from SAP ERP to SAP S/4HANA and working with service providers to navigate the financial and operational complexities involved, according to a
Comcast Business Partners with University of Virginia to Launch Innovative On-Campus Private Wireless Network Solution Featuring Cellular Carrier Integration
Comcast Business today announced the successful deployment of its groundbreaking Private Wireless Network solution at the University of Virginia (UVA) in Charlottesville, VA. In collaboration with
Upland Software Reports First Quarter 2025 Financial Results
Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced financial and operating results for the first quarter 2025 and issued guidance for
QuinStreet to Participate at Upcoming Investor Conferences
QuinStreet, Inc. (Nasdaq: QNST), a leader in performance marketplaces and technologies for the financial services and home services industries, today announced that management will participate at
Del Webb Announces Grand Opening of Two New Indianapolis-Area Communities
Del Webb, the nation's leading builder of active adult communities for those 55 and older, today announced the grand opening of two highly anticipated communities in the Indianapolis area
The Homes Americans Are Buying Are Older Than Ever
(NASDAQ: RDFN) — The typical home bought in the U.S. hit a record age of 36 years in 2024, according to a new report from Redfin (redfin.com), the technology-powered real estate brokerage. That’s
Adtran boosts DCI capabilities with dynamic AI Network Cloud solution
Adtran today announced its new AI Network Cloud (AINC)-interconnect solution, a next-generation fiber networking platform designed to support hyperscalers, federal agencies, SLED organizations and
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, today announced that
State Street Global Advisors Research Examines Investors’ Risk Awareness Amid Market Volatility
State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today released its ETFs in Focus Study: Risk Management Attitudes & Behaviors and its ETF Impact
REPLY: The Board of Directors Approves the Quarterly Report Dated 31 March 2025
Today, the Board of Directors of Reply S.p.A. [EXM, STAR: REY] approved the results as at 31 March 2025.
Since the beginning of the year, the Group has recorded a consolidated revenues amounting
GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system
GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending1 ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic
Redfin Reports U.S. Asking Rents Fell 1% Year Over Year in April—Biggest Drop in 14 Months
(NASDAQ: RDFN) — The median U.S. asking rent fell 1% year over year to $1,625 in April, marking the biggest decline since February 2024, according to a new report from Redfin (redfin.com), the
Chewy CFO David Reeder to Depart Chewy, Company Reaffirms First Quarter Guidance
Chewy, Inc. (NYSE: CHWY), a trusted destination for pet parents and partners everywhere, announced today that the Company’s Chief Financial Officer, David Reeder, will be departing in several
Northisle Commences Trading on the OTCQX Market Under the Symbol NTCPF
Northisle Copper and Gold Inc. (TSX-V: NCX) (“Northisle” or the “Company”) is pleased to announce that, effective today, the Company’s common shares will commence trading on the OTCQX® Best Market
Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three months ended March 31, 2025.
First Quarter 2025 Financial Results
-
Total Revenue: For the three
Dole plc Reports First Quarter 2025 Financial Results
Dole plc (NYSE: DOLE) ("Dole" or the "Group" or the "Company") today released its financial results for the three months ended March 31, 2025.
Highlights for the three months ended March 31,
German Firms Move to Cloud-Based SAP for Speed, Agility
Accelerated cloud adoption is reshaping the SAP ecosystem in Germany as enterprises shift toward the company’s cloud-based solutions despite ongoing concerns, according to a new research report


